Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 411

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 411
---
 | -14,883,124 | ​ | ​ |
| Total Stockholders’ Deficit                                                                                                                                                                                                                     | ​ | ​ | ​                  | ​ | -16,707,161 | ​ | ​ | ​ | ​                 | ​ | -14,742,434 | ​ | ​ |
| Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Deficit                                                                                                                                                        | ​ | ​ | ​                  | $ |   3,068,186 | ​ | ​ | ​ | ​                 | $ |   4,502,213 | ​ | ​ |

(1) As of September 30, 2024 and December 31, 2023, include $32,580 and $85,084, respectively of the restricted cash to be used for tax payments only.

The accompanying notes are an integral part of these unaudited condensed financial statements. F-2

TABLE OF CONTENTS

IRIS ACQUISITION CORP CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)

| ​                                                                                                          | ​ | ​ | Three Months EndedSeptember 30,2024 |   |            |   | ​ | ​ | Three Months EndedSeptember 30,2023 |   |           |   | ​ | ​ | Nine Months EndedSeptember 30,2024 |   |            |   | ​ | ​ | Nine Months EndedSeptember 30,2023 |   |            |   | ​ |
|:-----------------------------------------------------------------------------------------------------------|:--|:--|:------------------------------------|:--|-----------:|:--|:--|:--|:------------------------------------|:--|----------:|:--|:--|:--|:-----------------------------------|:--|-----------:|:--|:--|:--|:-----------------------------------|:--|-----------:|:--|:--|
| Formation and operating costs                                                                              | ​ | ​ | ​                                   | $ | -1,019,694 | ​ | ​ | ​ | ​                                   | $ |  -676,321 | ​ | ​ | ​ | ​                                  | $ | -2,383,530 | ​ | ​ | ​ | ​                                  | $ | -1,943,512 | ​ | ​ |
| Forgiveness of unrelated vendor payables                                                                   | ​ | ​ | ​                                   | ​ |          — | ​ | ​ | ​ | ​                                   | ​ |         — | ​ | ​ | ​ | ​                                  | ​ |